| Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine S Nölting, M Ullrich, J Pietzsch, CG Ziegler, G Eisenhofer, A Grossman, ... Cancers 11 (10), 1505, 2019 | 166 | 2019 |
| HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas N Bechmann, ML Moskopp, M Ullrich, B Calsina, PW Wallace, S Richter, ... Endocrine-related cancer 27 (11), 625-640, 2020 | 56 | 2020 |
| Three-dimensional cell culture systems in radiopharmaceutical cancer research A Doctor, V Seifert, M Ullrich, S Hauser, J Pietzsch Cancers 12 (10), 2765, 2020 | 50 | 2020 |
| Multimodal somatostatin receptor theranostics using [64Cu] Cu-/[177Lu] Lu-DOTA-(Tyr3) octreotate and AN-238 in a mouse pheochromocytoma model M Ullrich, R Bergmann, M Peitzsch, EF Zenker, M Cartellieri, M Bachmann, ... Theranostics 6 (5), 650, 2016 | 44 | 2016 |
| Impact of extrinsic and intrinsic hypoxia on catecholamine biosynthesis in absence or presence of Hif2α in pheochromocytoma cells N Bechmann, I Poser, V Seifert, C Greunke, M Ullrich, N Qin, A Walch, ... Cancers 11 (5), 594, 2019 | 39 | 2019 |
| Recent insights in barium-131 as a diagnostic match for radium-223: Cyclotron production, separation, radiolabeling, and imaging F Reissig, D Bauer, M Ullrich, M Kreller, J Pietzsch, C Mamat, K Kopka, ... Pharmaceuticals 13 (10), 272, 2020 | 34 | 2020 |
| Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC JP Sinnes, J Nagel, BP Waldron, T Maina, BA Nock, RK Bergmann, ... EJNMMI research 9, 1-11, 2019 | 28 | 2019 |
| Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses A Fischer, S Kloos, U Maccio, J Friemel, H Remde, M Fassnacht, ... The Journal of Clinical Endocrinology & Metabolism 108 (10), 2676-2685, 2023 | 25 | 2023 |
| Toward personalized medicine: One chelator for imaging and therapy with lutetium-177 and actinium-225 P Cieslik, M Kubeil, K Zarschler, M Ullrich, F Brandt, K Anger, H Wadepohl, ... Journal of the American Chemical Society 144 (47), 21555-21567, 2022 | 22 | 2022 |
| An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment D Huebner, C Rieger, R Bergmann, M Ullrich, S Meister, M Toma, ... BMC cancer 17, 1-12, 2017 | 22 | 2017 |
| In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma M Ullrich, R Bergmann, M Peitzsch, M Cartellieri, N Qin, ... Endocrinology 155 (11), 4149-4156, 2014 | 21 | 2014 |
| Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures K Wang, I Schütze, S Gulde, N Bechmann, S Richter, J Helm, M Lauseker, ... Endocrine-Related Cancer 29 (6), 285-306, 2022 | 20 | 2022 |
| Hif2alpha-associated pseudohypoxia promotes radioresistance in pheochromocytoma: Insights from 3d models V Seifert, S Richter, N Bechmann, M Bachmann, CG Ziegler, J Pietzsch, ... Cancers 13 (3), 385, 2021 | 17 | 2021 |
| “Clickable” albumin binders for modulating the tumor uptake of targeted radiopharmaceuticals F Brandt, M Ullrich, M Laube, K Kopka, M Bachmann, R Löser, ... Journal of Medicinal Chemistry 65 (1), 710-733, 2021 | 16 | 2021 |
| Design and biological evaluation of small-molecule PET-tracers for imaging of programmed death ligand 1 F Krutzek, CK Donat, M Ullrich, K Zarschler, MC Ludik, A Feldmann, ... Cancers 15 (9), 2638, 2023 | 15 | 2023 |
| Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells CG Ziegler, M Ullrich, AV Schally, R Bergmann, J Pietzsch, L Gebauer, ... Molecular and cellular endocrinology 371 (1-2), 189-194, 2013 | 15 | 2013 |
| Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: Morphologic and radiopharmacologic characterization V Seifert, J Liers, T Kniess, S Richter, N Bechmann, A Feldmann, ... Journal of Cellular Biotechnology 5 (2), 135-151, 2019 | 12 | 2019 |
| Strain-specific metastatic phenotypes in pheochromocytoma allograft mice M Ullrich, J Liers, M Peitzsch, A Feldmann, R Bergmann, U Sommer, ... Endocrine-Related Cancer 25 (12), 993-1004, 2018 | 11 | 2018 |
| Enzymological Characterization of 64Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals F Brandt, M Ullrich, J Wodtke, K Kopka, M Bachmann, R Löser, ... Journal of Medicinal Chemistry 66 (1), 516-537, 2023 | 9 | 2023 |
| Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo M Friedemann, B Nacke, A Hagelgans, C Jandeck, N Bechmann, ... Oncotarget 9 (89), 35983, 2018 | 9 | 2018 |
